XML 28 R8.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2022
Dec. 31, 2021
Dec. 31, 2020
Statement of Cash Flows [Abstract]      
Cash and cash equivalents at beginning of year $ 439,272 $ 746,724 $ 613,110
Cash flows from operating activities:      
Net income 2,815,131 199,942 446,615
Adjustments to reconcile net income to cash flows from operating activities:      
Depreciation and amortization 300,841 254,000 231,984
Gain on sale of business/interest in properties, net 8,400 (295,971) (7,168)
Stock-based compensation and other 30,474 20,120 22,837
Equity in net income of unconsolidated investments (net of tax) (772,275) (95,770) (127,521)
Dividends received from unconsolidated investments and nonmarketable securities 801,239 78,391 88,161
Pension and postretirement (benefit) expense (52,254) (74,010) 45,658
Pension and postretirement contributions (16,112) (30,253) (16,434)
Unrealized gain on investments in marketable securities 3,279 (3,818) (4,635)
Loss on early extinguishment of debt 19,219 28,955 0
Deferred income taxes 93,339 (38,500) (1,976)
Changes in current assets and liabilities, net of effects of acquisitions and divestitures:      
(Increase) decrease in accounts receivable (786,121) (49,295) 100,118
(Increase) decrease in inventories (1,609,642) (127,401) 51,978
(Increase) decrease in other current assets (104,655) 17,411 7,902
Increase (decrease) in accounts payable 1,287,072 143,939 (31,519)
(Decrease) increase in accrued expenses and income taxes payable (201,356) 127,068 (215,011)
Non-cash transfer of 40% value of construction in progress of Kemerton plant to MRL 122,682 135,928 179,437
Other, net (31,412) 53,521 28,488
Net cash provided by operating activities 1,907,849 344,257 798,914
Cash flows from investing activities:      
Acquisitions, net of cash acquired (162,239) 0 (22,572)
Capital expenditures (1,261,646) (953,667) (850,477)
Cash proceeds from divestitures, net 0 289,791 0
Proceeds from sale of joint venture 0 0 11,000
Sales of marketable securities, net 1,942 3,774 903
Investments in equity and other corporate investments (706) (6,488) (2,427)
Net cash used in investing activities (1,422,649) (666,590) (863,573)
Cash flows from financing activities:      
Proceeds from issuance of common stock 0 1,453,888 0
Proceeds from borrowings of other long-term debt 1,964,216 0 452,163
Repayments of long-term debt and credit agreements (705,000) (1,173,823) (250,000)
Other (repayments) borrowings, net (391,662) 60,991 137,635
Fees related to early extinguishment of debt (9,767) (24,877) 0
Dividends paid to shareholders (184,429) (177,853) (161,818)
Dividends paid to noncontrolling interests (44,208) (96,136) (32,061)
Proceeds from exercise of stock options 2,783 18,392 40,437
Withholding taxes paid on stock-based compensation award distributions (13,338) (8,140) (5,143)
Other (6,708) (2,230) (3,952)
Net cash provided by financing activities 611,887 50,212 177,261
Net effect of foreign exchange on cash and cash equivalents (37,217) (35,331) 21,012
Increase (decrease) in cash and cash equivalents 1,059,870 (307,452) 133,614
Cash and cash equivalents at end of year $ 1,499,142 $ 439,272 $ 746,724